These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20452798)

  • 21. Antibodies against pneumococcal capsular polysaccharide in Malawian HIV-positive mothers and their HIV-exposed uninfected children.
    Baroncelli S; Galluzzo CM; Mancinelli S; Andreotti M; Jere H; Amici R; Marazzi MC; Vella S; Palombi L; Giuliano M
    Infect Dis (Lond); 2016 Apr; 48(4):317-321. PubMed ID: 26609569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effect of Human Immunodeficiency Virus and Cytomegalovirus Infection on Infant Responses to Vaccines: A Review.
    Falconer O; Newell ML; Jones CE
    Front Immunol; 2018; 9():328. PubMed ID: 29552009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional and genetic predisposition to rhinovirus lower respiratory tract infections in prematurely born infants.
    Drysdale SB; Alcazar M; Wilson T; Smith M; Zuckerman M; Hodemaekers HM; Janssen R; Bont L; Johnston SL; Greenough A
    Eur J Pediatr; 2016 Dec; 175(12):1943-1949. PubMed ID: 27695990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal immune responses and risk of infant infection with HIV-1 after a short course Zidovudine in a cohort of HIV-1 infected pregnant women in rural Kenya.
    Makokha EP; Songok EM; Orago AA; Koech DK; Chemtai AK; Kobayashi N; Mpoke S; Tukei PM; Andayi FA; Lihana RW; Adungo NI; Vulule JM
    East Afr Med J; 2002 Nov; 79(11):567-73. PubMed ID: 12630488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: An analysis of the women and infants transmission study.
    Pacheco SE; McIntosh K; Lu M; Mofenson LM; Diaz C; Foca M; Frederick M; Handelsman E; Hayani K; Shearer WT;
    J Infect Dis; 2006 Oct; 194(8):1089-97. PubMed ID: 16991083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of human immunodeficiency virus infection on birthweight, and infant and child mortality in urban Malawi.
    Taha TE; Dallabetta GA; Canner JK; Chiphangwi JD; Liomba G; Hoover DR; Miotti PG
    Int J Epidemiol; 1995 Oct; 24(5):1022-9. PubMed ID: 8557435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers.
    Bunders M; Thorne C; Newell ML;
    AIDS; 2005 Jul; 19(10):1071-9. PubMed ID: 15958839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns and predictors of CD4 T-cell counts among children born to HIV-infected women in Tanzania.
    Kupka R; Msamanga GI; Aboud S; Manji KP; Duggan C; Fawzi WW
    J Trop Pediatr; 2009 Oct; 55(5):290-6. PubMed ID: 19158163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.
    Culnane M; Fowler M; Lee SS; McSherry G; Brady M; O'Donnell K; Mofenson L; Gortmaker SL; Shapiro DE; Scott G; Jimenez E; Moore EC; Diaz C; Flynn PM; Cunningham B; Oleske J
    JAMA; 1999 Jan; 281(2):151-7. PubMed ID: 9917118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of mother-to-child transmission of HIV in pregnancy and among HIV-exposed infants accessing care at a PMTCT clinic in southwest Nigeria.
    Afolabi AY; Bakarey AS; Kolawole OE; Kola OJ
    J Immunoassay Immunochem; 2018; 39(4):403-415. PubMed ID: 30001188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Function and phenotype of immature CD4+ lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers.
    Rich KC; Siegel JN; Jennings C; Rydman RJ; Landay AL
    Clin Diagn Lab Immunol; 1997 May; 4(3):358-61. PubMed ID: 9144377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants.
    Feiterna-Sperling C; Weizsaecker K; Bührer C; Casteleyn S; Loui A; Schmitz T; Wahn V; Obladen M
    J Acquir Immune Defic Syndr; 2007 May; 45(1):43-51. PubMed ID: 17356471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maternal and infant factors predicting disease progression in human immunodeficiency virus type 1-infected infants. Women and Infants Transmission Study Group.
    Rich KC; Fowler MG; Mofenson LM; Abboud R; Pitt J; Diaz C; Hanson IC; Cooper E; Mendez H
    Pediatrics; 2000 Jan; 105(1):e8. PubMed ID: 10617745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 mother-to-child transmission and drug resistance among Brazilian pregnant women with high access to diagnosis and prophylactic measures.
    Alcântara KC; Lins JB; Albuquerque M; Aires LM; Cardoso LP; Minuzzi AL; Stefani MM
    J Clin Virol; 2012 May; 54(1):15-20. PubMed ID: 22317908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
    Gibb DM; Kizito H; Russell EC; Chidziva E; Zalwango E; Nalumenya R; Spyer M; Tumukunde D; Nathoo K; Munderi P; Kyomugisha H; Hakim J; Grosskurth H; Gilks CF; Walker AS; Musoke P;
    PLoS Med; 2012; 9(5):e1001217. PubMed ID: 22615543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of congenital cytomegalovirus infection among HIV-exposed uninfected infants is not decreased by maternal nelfinavir use during pregnancy.
    Gantt S; Leister E; Jacobsen DL; Boucoiran I; Huang ML; Jerome KR; Jourdain G; Ngo-Giang-Huong N; Burchett S; Frenkel L
    J Med Virol; 2016 Jun; 88(6):1051-8. PubMed ID: 26519647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to Bacille Calmette-Guérin (BCG) vaccine in HIV-uninfected infants.
    Miles DJ; Gadama L; Gumbi A; Nyalo F; Makanani B; Heyderman RS
    Immunology; 2010 Mar; 129(3):446-54. PubMed ID: 20002789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation and Operational Research: Maternal Combination Antiretroviral Therapy Is Associated With Improved Retention of HIV-Exposed Infants in Kinshasa, Democratic Republic of Congo.
    Feinstein L; Edmonds A; Okitolonda V; Cole SR; Van Rie A; Chi BH; Ndjibu P; Lusiama J; Chalachala JL; Behets F
    J Acquir Immune Defic Syndr; 2015 Jul; 69(3):e93-9. PubMed ID: 25886922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants?
    Kuhn L; Kasonde P; Sinkala M; Kankasa C; Semrau K; Scott N; Tsai WY; Vermund SH; Aldrovandi GM; Thea DM
    Clin Infect Dis; 2005 Dec; 41(11):1654-61. PubMed ID: 16267740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High Burden of Morbidity and Mortality but Not Growth Failure in Infants Exposed to but Uninfected with Human Immunodeficiency Virus in Tanzania.
    Locks LM; Manji KP; Kupka R; Liu E; Kisenge R; McDonald CM; Aboud S; Wang M; Fawzi WW; Duggan CP
    J Pediatr; 2017 Jan; 180():191-199.e2. PubMed ID: 27829511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.